Single blood test screens for eight cancer types 22 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have developed a single blood test that screens for eight common cancer types and helps identify the location of cancer...
Pixelated gene expression tool provides fast accurate results for RNA analysis 22 January 2018 | By Drug Target Review Researchers have demonstrated how a pixelated gene expression tool can accurately measure RNA levels more quickly than existing methods allow.
Synthetic horsepox virus could lead to more effective smallpox vaccine 22 January 2018 | By Dr Zara Kassam (Drug Target Review) Synthetic technology breakthrough points to safer vaccines and targeted cancer treatments...
Genomic tools reveal diverse behaviour in immune cells 22 January 2018 | By Drug Target Review New research from La Jolla Institute for Allergy and Immunology using single-cell transcriptome analysis yields greater understanding of the human immune system.
New study suggests possible marker to test patient immunotherapy benefit 19 January 2018 | By Drug Target Review While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.
HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection 19 January 2018 | By Dr Zara Kassam (Drug Target Review) New evidence supports the existence of genetic 'sieve' on the path from vaginal tract to bloodstream...
The Down’s syndrome “super genome” 19 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have found that children born with Down’s syndrome have an excellent genome – better, in fact than the average genome of people without the genetic abnormality...
EXD2 enzyme identified as key player in mitochondrial protein synthesis 19 January 2018 | By Drug Target Review A team of researchers led by IRB Barcelona in Spain have identified a key function of the enzyme EXD2 as being the maintenance of protein production in the mitochondria.
HLF gene protects blood stem cells by maintaining them in a resting state 19 January 2018 | By Drug Target Review The HLF gene is necessary for maintaining our blood stem cells in a resting state, which is crucial for ensuring normal blood production.
Research enables screening millions of human antibodies for new drug discovery 18 January 2018 | By Drug Target Review Researchers have outlined a pioneering method of screening a person’s diverse set of antibodies for rapid therapeutic discovery.
G-CSF protein involved in cocaine addiction 18 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have identified a protein produced by the immune system that could be responsible for the development of cocaine addiction...
Study reveals how MRSA infection compromises lymphatic function 18 January 2018 | By Drug Target Review MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Final numbers are in: 42 million protein molecules in a yeast cell 18 January 2018 | By Drug Target Review Researchers have officially revealed the abundance of protein molecules in a single cell runs into the tens of millions: around 42 million, to be precise.
New study offers insights on genetic indicators of COPD risk 17 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who are particularly at risk for COPD...
Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate 17 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered that synthetic APC-mimicking molecules provide anti-inflammatory and anti-thrombotic protection to endothelial cells without interfering with blood clotting...
